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Introduction
Epithelial-to-mesenchymal transition (EMT) has emerged as a
cardinal process crucial to the promotion of tissue fibrosis and
metastasis (Kalluri and Neilson, 2003), and multiple mediators and
regulators of EMT have been identified (Gotzmann et al., 2004;
Thiery and Sleeman, 2006). The EMT phenotype represents a
striking manifestation of epithelial plasticity that encompasses
dissolution of tight junctions, modulation of adherens junctions,
reorganization of the actin cytoskeleton, loss of apical-basal polarity
and the induction of a mesenchymal gene expression program
(Ozdamar et al., 2005; Thiery, 2002; Zavadil and Bottinger, 2005).
The cytokine transforming growth factor β1 (TGF-β1) has been
identified as a potent inducer of EMT in numerous cell types (Lee
et al., 2006). Although a role for EMT in the development of kidney
fibrosis is well recognized (Iwano et al., 2002), a role for EMT in
fibrogenesis of the lung was unclear until recently, when multiple
studies highlighted the fact that TGF-β1 could induce EMT in rat
or human alveolar type II epithelial cells (Jain et al., 2007; Kasai
et al., 2005; Kim et al., 2006; Willis et al., 2005). Evidence for
EMT was also recently reported in lung biopsies from patients with
idiopathic pulmonary fibrosis (IPF) (Kim et al., 2006; Wang et al.,
2006), and in mouse models of fibrosis (Kim et al., 2006; Wu et
al., 2007).
Jun N-terminal kinase (JNK) is a member of the family of
mitogen-activated protein kinases (MAPK) that is well known for
its role in stress responses and regulation of apoptosis (Davis, 2000).
Recent studies have identified evidence for crosstalk between JNK
and TGF-β1 signaling pathways. For example, TGF-β-activated
kinase 1 (TAK-1) can mediate the activation of JNK1 (Hocevar et
al., 2005; Mori et al., 2004; Verrecchia et al., 2001). TGF-β1-
induced Smad2 and Smad3 phosphorylation has been shown to be
JNK-dependent (Wang et al., 2006), and contributes to the
transcriptional upregulation of select mesenchymal genes (Kasai et
al., 2005; Mori et al., 2004; Xie et al., 2005). A recent study revealed
that TGF-β1-mediated loss of caveolin-1 is a crucial regulatory event
in the pathophysiology of pulmonary fibrosis, in association with
the activation of JNK1 in fibroblasts (Wang et al., 2006).
Furthermore, the activity of JNK was shown to be elevated in
fibroblasts from patients with chronic pulmonary fibrosis, and
facilitated TGF-β1-driven endothelin-1 expression (Shi-Wen et al.,
2006).
These collective findings suggest that JNK signaling may be
required for TGF-β1-induced fibrogenesis of the lung, via a process
that may involve EMT. Therefore, the goal of the present study was
to determine whether the activity of JNK in primary cultures of
airway epithelial cells is required for TGF-β1-induced EMT, and
to elucidate the potential mechanisms by which JNK affects TGF-
β1-induced signaling.
Results
Characterization of primary epithelial cells in culture
In order to test the impact of TGF-β1 on airway epithelial cells,
primary cultures of mouse tracheal epithelial cells (MTEC) were
established. MTEC expressed the epithelial marker proteins E-
cadherin and cytokeratin and were negative for the mesenchymal
markers, fibronectin 1 and α-smooth muscle actin (SMA) (Fig. 1A).
Transforming growth factor β1 (TGF-β1) is a cardinal cytokine
in the pathogenesis of airway remodeling, and promotes
epithelial-to-mesenchymal transition (EMT). As a molecular
interaction between TGF-β1 and Jun N-terminal kinase (JNK)
has been demonstrated, the goal of this study was to elucidate
whether JNK plays a role in TGF-β1-induced EMT. Primary
cultures of mouse tracheal epithelial cells (MTEC) from wild-
type, JNK1–/– or JNK2–/– mice were comparatively evaluated
for their ability to undergo EMT in response to TGF-β1. Wild-
type MTEC exposed to TGF-β1 demonstrated a prominent
induction of mesenchymal mediators and a loss of epithelial
markers, in conjunction with a loss of trans-epithelial resistance
(TER). Significantly, TGF-β1-mediated EMT was markedly
blunted in epithelial cells lacking JNK1, while JNK2–/– MTEC
underwent EMT in response to TGF-β1 in a similar way to wild-
type cells. Although Smad2/3 phosphorylation and nuclear
localization of Smad4 were similar in JNK1–/– MTEC in
response to TGF-β1, Smad DNA-binding activity was
diminished. Gene expression profiling demonstrated a global
suppression of TGF-β1-modulated genes, including regulators
of EMT in JNK1–/– MTEC, in comparison with wild-type cells.
In aggregate, these results illuminate the novel role of airway
epithelial-dependent JNK1 activation in EMT.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/121/7/1036/DC1
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1037JNK1 regulates TGF-β1-induced EMT
Conversely, primary lung fibroblasts were
positive for mesenchymal markers and
negative for epithelial markers. MTEC cultures
established well-defined rings of the tight
junction protein zona occludens 1 (ZO-1),
indicative of tight junction formation, a
predominant characteristic of polarized
epithelial monolayers (Fig. 1B). Scanning and
transmission electron micrographs of MTEC
in culture also showed well-defined cell-cell
contacts and epithelial cell morphology (Fig.
1C,D), and when grown on air-liquid interface
(ALI), MTEC established tight junctions and
desmosomes. (Fig. 1C,D). To confirm that
MTEC cultures establish functional tight
junctional complexes, trans-epithelial
resistance (TER) was measured, and revealed
that over time in culture, cells established a
high TER (Fig. 1E). Under submerged culture
conditions, MTEC displayed a higher TER
than previously reported on ALI (You et al.,
2002). Indeed, MTEC cultures that were grown
on ALI in the presence or absence of retinoic
acid displayed a reduced level of TER,
consistent with previously reported values.
Collectively, these data demonstrate that the primary MTEC cultures
that were established here express multiple epithelial markers and
form tight junctions in vitro.
TGF-β1 induces an EMT phenotype in MTEC
Although EMT has been demonstrated in alveolar epithelial cells,
it is not clear whether epithelial cells derived from proximal airways
can also undergo EMT. Indeed, MTEC exposed to TGF-β1
demonstrated increased expression of collagen type 1a1 and
fibronectin 1, two mesenchymal protein markers. As expected,
expression of the epithelial marker, E-cadherin decreased in MTEC
following exposure to TGF-β1 (Fig. 2A). TGF-β1 also enhanced
expression of α-SMA, and PAI-1 protein, in lysates or supernatants,
respectively (Fig. 2B). These changes in protein content were
accompanied by changes in mRNA expression. Results in Fig. 2C
demonstrate that cells exposed to TGF-β1 increased mRNA
expression of collagen type 1a1, fibronectin 1 and PAI-1, whereas
they decreased mRNA content of clara cell secretory protein
(CCSP), a transcript selectively expressed in airway epithelial cells.
These collective shifts in expression from epithelial to mesenchymal
markers that are induced by TGF-β1 in MTEC are a hallmark of
EMT (Lee et al., 2006). To determine whether the observed
epithelial plasticity was reversible, MTEC were grown in TGF-β1-
containing medium for 10 days and were then maintained for an
additional 6 days in the absence of TGF-β1. Although expression
of TGF-β1-induced mesenchymal markers decreased to control
levels following MTEC recovery, expression of the epithelial
marker CCSP did not recover within this time frame (Fig. 2C).
Nonetheless, these results suggest that TGF-β1 induced a transient
EMT phenotype in MTEC.
Activation of JNK and TGF-β1 signaling in MTEC
We first assessed whether TGF-β1 activates the canonical Smad
signaling pathway in MTEC. As is demonstrated in Fig. 3A,B, TGF-
β1 induced Smad2 phosphorylation, Smad4 nuclear accumulation
and increased binding of nuclear proteins to Smad DNA-binding
elements (SBE). Evaluation of phosphorylation of JNK1 and 2
demonstrated that exposure to 5 ng/ml TGF-β1 caused increases
Fig. 1. Characterization of primary MTEC.
(A) Compared to isolated lung fibroblasts, MTEC
expressed cytokeratins and E-cadherin, but were
negative for fibronectin and α-SMA. (B) MTEC
expressed the localized tight junctional protein ZO-1,
indicative of barrier function (ZO-1 is depicted by the
red stain, whereas the green signal represents the
DNA counterstain, Sytox Green). (C) Scanning
electron micrograph of MTEC depicting well-defined
cell-cell contacts, 2500 magnification.
(D) Transmission electron micrograph depicting tight
junction formation, desmosomes, nuclei, vacuole;
15000 magnification. (E) Primary MTEC
established stable TER in culture. Shown are MTEC
cultured under submerged conditions, or cultured on
ALI in the presence of absence of retinoic acid (30
nM); TER was measured every other day for 18 days.
D, desmosome; N, nucleus; T, tight junction; V,
vacuole.
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in phosphorylation of JNK1 and JNK2, which were apparent after
1 hour and further increased after 4 hours of exposure (Fig. 3C).
These findings demonstrate that TGF-β1 is capable of inducing JNK
and Smad pathway activation in airway epithelial cells.
JNK1 is required for TGF-β1-induced EMT in MTEC
Two isoforms of JNK, JNK1 and 2 are expressed in airway
epithelial cells. To elucidate the respective roles of JNK1 or JNK2
in TGF-β1-induced EMT, MTEC were isolated from wild-type,
JNK1–/– or JNK2–/– mice and evaluated comparatively for a TGF-
β1-induced loss in TER (Fig. 4A), as an indication of dissolution
of tight junctions and barrier function (Lee et al., 2006). As expected,
TGF-β1 caused a decrease in TER in wild-type MTEC cultures.
Although JNK2–/– cells were protected from TGF-β1-induced loss
of TER between 3 and 6 days, at later time points a similar loss in
TER was observed in JNK2–/– cells compared to wild-type cells
(Fig. 4A). By contrast, JNK1–/– MTEC were markedly protected
against the decrease in TER induced by TGF-β1 at all time points
evaluated. Consistent with these findings, TGF-β1 enhanced
expression of the mesenchymal protein α-SMA in wild-type and
to a slightly lesser extent in JNK2–/– MTEC, but failed to do so in
Journal of Cell Science 121 (7)
JNK1–/– MTEC (Fig. 4B). Western blot analysis for total JNK
confirmed that MTEC from JNK1–/– and JNK2–/– mice indeed
lacked JNK1 or JNK2, respectively (Fig. 4C). These data indicate
that the TGF-β1-induced EMT in MTEC is JNK1-dependent, and
appears to be largely independent of JNK2.
Wild-type and JNK1–/– MTEC display similar phenotypes in
culture
The failure of JNK1–/– MTEC to undergo EMT may be due to an
intrinsic inability of these cells to differentiate. We therefore further
characterized the phenotype of JNK1–/– MTEC compared to wild-
type cells. Although JNK1–/– MTEC plated at a higher density, the
rate of growth was similar between wild-type and JNK1–/– cells
(Fig. 5A, Fig. 4B). JNK1–/– and wild-type MTEC appeared
phenotypically similar (Fig. 5B). When cultured on ALI in the
presence of retinoic acid, JNK1–/– and wild-type MTEC also
produced similar levels of mucins, a characteristic of differentiation
of airway epithelial cells (Fig. 5C) (Gray et al., 2001). These data
strongly suggest that JNK1–/– MTEC are not intrinsically incapable
of differentiation, but have a selective defect in plasticity towards
EMT.
Fig. 2. Assessment of effects of TGF-β1 in MTEC on expression of mesenchymal and epithelial markers. (A) Evaluation of collagen type 1a1, fibronectin and E-
cadherin via immunofluorescence. MTEC were exposed to 5 ng/ml TGF-β1 every other day for 14 days, and prepared for immunofluorescence. Magnification
400. DAPI illustrates nuclei. (B) MTEC were exposed to 5 ng/ml TGF-β1, and expression of PAI-1 was assessed in cell culture media 24 hours later. α-SMA
protein expression was determined in cell lysates following exposure to 0.5 or 5 ng/ml of TGF-β1 for 6 days. Smad3 represents loading control. Different lanes
shown represent results from independent samples. (C) Evaluation of mRNA levels of mesenchymal or epithelial genes in MTEC exposed to TGF-β1 treatment (5
ng/ml, every other day for 10 days). To evaluate reversibility of TGF-β1 responses, MTEC were maintained in culture for 6 additional days in the absence of TGF-
β1. mRNA expression was evaluated by real-time PCR analysis, and data normalized to the housekeeping gene HPRT. Results are expressed as fold changes from
controls. * P<0.05, ANOVA versus control-treated, ** P<0.05, ANOVA versus TGF-β1-treated.
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JNK1 promotes TGF-β1-induced gene expression
To determine whether JNK1 affected TGF-β1-induced
transcriptional responses in primary lung epithelial cells, gene
expression profiles were evaluated comparatively in MTEC from
wild-type and JNK1–/– mice by microarray analyses. TGF-β1
caused marked increases in expression of mesenchymal genes and
a loss of epithelial specific transcripts in wild-type cells, consistent
with the induction of EMT (Table 1). By contrast, MTEC derived
from JNK1–/– mice showed markedly blunted responses to TGF-
β1 when evaluating global gene expression profiles, in addition to
genes that reflect EMT (Table 1, Fig. 6A). Real-time PCR analyses
of mesenchymal (collagen type 1a1, fibronectin 1, plasminogen
activator inhibitor 1) and epithelial (CCSP) genes (Fig. 6B),
confirmed that the presence of JNK1 is required for a maximal TGF-
β1-induced EMT transcriptional program in MTEC. Several
transcription factors involved in the induction of EMT have been
identified (Lee et al., 2006; Thiery and Sleeman, 2006; Venkov et
al., 2007). TGF-β1 induced the EMT regulators HMGA2, Ets-1
and Jagged 1 in a JNK1-dependent manner (Fig. 6C). Collectively,
these data highlight a crucial requirement of JNK1 in the causation
of TGF-β1-induced EMT in isolated primary airway epithelial cells.
To confirm that the lack of EMT in JNK1–/– primary MTEC cells
is due to ablation of JNK1 instead of other compensatory changes,
we used a generic JNK1 inhibitor. MTEC cells treated with 10 μM
SP600125 demonstrated marked protection against TGF-β1-induced
Fn and PAI-1 mRNA expression (supplementary material Fig. S1).
Lastly, SiRNA-mediated knockdown of JNK1 in a line of epithelial
cells also diminished TGF-β1-induced mRNA expression of PAI-
1 (supplementary material Fig. S2), demonstrating that acute
disruption of the JNK pathway attenuates TGF-β1-regulated EMT.
Altered TGF-β1 pathway activation in JNK1–/– epithelial cells
The attenuated TGF-β1-induced transcriptional responses in
JNK1–/– cells could potentially be explained by attenuated Smad
signaling in JNK1–/– MTEC. Results shown in Fig. 7A demonstrate
that TGF-β1 caused increases in phospho-Smad2/3 and Smad4 in
nuclear extracts to similar extents to those in wild-type and JNK1–/–
MTEC (Fig. 7A), indicating that TGF-β1-receptor-driven
phosphorylation of receptor Smads and recruitment of Smad4 to
the nucleus were not different between wild-type and JNK1–/–
MTEC. However, increases in the binding of Smad3/4 to the SBE
induced by TGF-β1 were attenuated in JNK1–/– epithelial cells,
demonstrating that the presence of JNK1 is essential for maximal
TGF-β1-induced Smad DNA binding (Fig. 7B). As expected, TGF-
β1-stimulated increases in nuclear phospho-Jun levels were
diminished in JNK1–/– cells compared with wild-type counterparts.
Fig. 3. Evaluation of Smad and JNK signaling in MTEC exposed to TGF-β1.
(A) Assessment of Smad2 phosphorylation and Smad4 nuclear localization in
MTEC in response to TGF-β1. Phospho-Smad2 and Smad4 were analyzed by
western blot of nuclear extracts, after 120 or 240 minutes of exposure to 5
ng/ml TGF-β1. Note that samples were run on the same gels, but irrelevant
lanes were deleted for consistency of presentation. (B) Electrophoretic
mobility shift assay evaluating binding of nuclear proteins to the consensus
SBE in response to TGF-β1 (10 ng/ml) for the indicated times.
(C) Assessment of phosphorylation of JNK1 and JNK2 following stimulation
of MTEC with TGF-β1 (5 ng/ml) for the indicated times. The upper band
indicates predominantly JNK2, whereas the lower band mainly reflects JNK1.
Fold change denotes differences in signal compared to sham controls based
upon densitometric evaluation. The lower panel represents total JNK1 and 2
western blot as loading control. Duplicate lanes in panels A, B and C represent
results from independent samples.
Table 1. Microarray analysis of TGF-β1-modulated genes in
wild-type or JNK1–/– MTECs 
Gene name/symbol Wild type JNK1–/–
Extracellular matrix and adhesion
TNFR superfamily 11b 9.92 4.72
Fibronectin 1 6.92 2.38
Serine peptidase inhibitor clade I 1 4.56 2.35
Latent TGF-β binding protein 1 3.23 1.59
Cadherin 6 3.14 2.11
Cadherin 10 2.83 1.27
Plasminogen activator inhibitor 1 2.53 1.96
Procollagen type 5a2 2.51 1.54
Protocadherin α1 2.06 –1.01
Procollagen 2 oxoglut. 5-dioxygen. 2 2.01 1.20
Tissue inhibitor metalloproteinase 3 –2.20 –1.17
Cytoskeleton
Lactate dehydrogenase b 2.51 1.33
Myosin light chain kinase 2.33 –1.02
α-actin 1 2.22 2.97
Palladin 2.10 1.52
Anillin –2.00 –1.27
Myozenin 2 –2.07 –1.27
Small proline-rich protein 1b –2.58 –1.39
Keratin 16 –3.73 –1.49
Keratin 13 –8.94 –3.94
Cell division and growth
Colony stimulating factor 2 4.66 1.87
Vascular endothelial growth factor C 2.17 1.24
Death associated kinase 2 2.14 1.54
Colony stimulating factor 1 2.13 1.39
Cell division cycle 20 –2.10 –1.21
Cyclin D1 –2.17 –1.62
Cyclin A2 –2.45 –1.16
Topoisomerase 2a –2.48 –1.59
Cell motility
Secreted phosphoprotein 1 5.31 2.16
Roundabout homolog 1 3.71 1.83
EMT regulators
Jagged 1 2.03 –1.22
Wnt5a 1.97 1.12
HMGA2 1.84 1.03
Data are grouped by gene ontology, and fold expression changes are shown
(positive value for increased, – for decreased compared with sham controls).
All genes listed showed a significant interaction with the presence of JNK1
(P<0.05) and were changed at least twofold compared with sham controls,
with the exception of the EMT-regulatory genes.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1040
These data suggest a role of JNK1 in modulating TGF-β1 signaling
at the level of DNA binding and transcriptional activation.
Discussion
The lineages of the cells crucial to the pathogenesis of pulmonary
fibrosis have been enigmatic. Whereas circulating fibrocytes or
activation of local tissue fibroblasts have been considered as
putative sources for production of mesenchymal products
(Garantziotis et al., 2004; Schmidt et al., 2003), recent evidence
has culminated to support the causal role of epithelial cells in the
process of tissue remodeling, via the process of EMT. The findings
from the present study identify the potential importance of epithelial
cells in fibrogenesis through a number of observations and elucidate
some key signals relevant to fibrosis. First, we demonstrated that
TGF-β1 induced EMT using a well-defined model of primary lung
epithelial cells (MTEC). Next, we unraveled the significance of
JNK1 in EMT by demonstrating that JNK1–/– MTEC were markedly
protected from TGF-β1-induced EMT. Then, we showed that Smad
DNA-binding activity and induction of known EMT transcriptional
regulators were attenuated in JNK1–/– MTEC compared with wild-
type cells. Collectively, the present data highlight the functional
importance of an epithelial TGF-β1-JNK1 signaling axis in EMT,
which might be cardinal to the pathophysiology of pulmonary
remodeling, including fibrosis. It is relevant to note that with the
exception of one set of experiments our studies were conducted in
primary epithelial cells that were isolated and propagated in culture
in order to maintain their differentiated state. Our experimental
design is of significance, as the process of EMT is linked to
Journal of Cell Science 121 (7)
transformation and carcinogenesis (Tse and Kalluri, 2007), and
experiments conducted in transformed cell lines therefore have
potential limited utility towards unraveling biochemical signals that
are regulators of EMT.
The present findings are supported by a number of previous
studies. Analysis of gene expression profiles in lungs of mice
subjected to sensitization and challenge with ovalbumin using laser
capture microdissection revealed that the most prominent induction
of mesenchymal genes occurred in airway epithelial captures, with
gene induction being less robust or absent in parenchymal regions
or captures of smooth muscle (Kelly et al., 2005). Furthermore,
lineage-tracing studies in models of kidney or pulmonary fibrosis
also provided unequivocal genetic evidence to support the notion
that epithelial cells provide a source for expansion of mesenchymal
cells and mesenchymal products (Iwano et al., 2002; Kim et al.,
2006). Lastly, fibroblastic cells that express both epithelial and
mesenchymal markers can be found in biopsies of humans with
IPF, highlighting the significance of EMT in vivo (Kim et al., 2006).
Whereas pulmonary alveolar Type II pneumocytes were shown to
undergo EMT in response to TGF-β1 in vitro and in vivo (Kasai
et al., 2005; Kim et al., 2006; Willis et al., 2005), the current study
clearly demonstrates the plasticity of epithelial cells in proximal
airways. Additional studies will be needed to identify the locales
at which EMT occurs in vivo, which are likely to be dependent on
the source and nature of the fibrogenic stimulus.
The present study, which utilizes primary tracheal epithelial cells
in vitro, unravels the importance of JNK1 in the process of EMT,
and highlights the functional interplay of JNK1 with the TGF-β1
Fig. 4. TGF-β1 induces EMT in MTEC in a
JNK1-dependent, but JNK2-independent,
manner. (A) TGF-β1-induced loss of TER,
indicative of barrier disruption, in wild-type
MTEC is abrogated in MTEC lacking
JNK1–/–, but not in JNK2–/– MTEC. Cells
were exposed to 5 ng/ml TGF-β1 every other
day for the indicated days of culture. Data are
graphed as percentage change in TER from
baseline, as recorded over a time period of 10
days. Results represent three independent
experiments. Absolute TER readings (Ohms
 cm2) before initiation of TGF-β1 exposure
were: wild type 1143.3±149.2; JNK1–/–
3521.7±161.4; JNK2–/– 2956.7±150.5
(n=6/group). (B) Comparative evaluation of
α-SMA expression in wild-type, JNK1–/– and
JNK2–/– MTEC, exposed to TGF-β1 (10
ng/ml, every other day for 8 days). α-SMA
expression (Red) was detected by
immunofluorescence. Green, Nuclear
counterstain, Sytox). The percentage of α-
SMA expressing cells was quantified by
counting the number of positive cells per
field (n>50 cells). (C) Confirmation of
genotypes of JNK1–/– or JNK2–/– MTEC by
western blot analysis of total JNK.
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signaling cascade in airway epithelial cells. Although comparative
evaluation of JNK2–/– MTEC did not demonstrate marked protection
from TGF-β1-induced EMT, a role for JNK2 in this process cannot
be fully excluded, based upon our data demonstrating some transient
protection from TGF-β1-induced loss of TER (Fig. 4A), and the
trends towards attenuated α-SMA expression in JNK2–/– MTEC
compared with wild-type counterparts, in addition to the differences
in staining patterns of α-SMA observed in JNK2–/– cells compared
with controls (Fig. 4B). Additional studies are therefore needed to
formally unravel the role of JNK2 in the process of EMT.
Our present findings are supported by a study demonstrating that
a pharmacological inhibitor of JNK, CEP-1347, attenuated the
phenotypic conversion of human lung fibroblasts to myofibroblasts
induced by IL-4 and IL-13 (Hashimoto et al., 2001). In addition,
an inhibitor of JNK or antisense RNA constructs blocked TGF-β1-
induced mesenchymal gene expression in a keratinocyte cell line
(Santibanez, 2006). Furthermore, a recent study demonstrated that
degradation of caveolin-1 plays a crucial role in lung fibrosis, and,
importantly, that the loss of caveolin-1 was crucial in the activation
of JNK in response to TGF-β1 in lung fibroblasts (Wang et al.,
2006). The same authors also demonstrated evidence for JNK
phosphorylation in lung tissue from patients with IPF, in support
of the functional significance of JNK in fibrogenesis in the lung.
The mechanism by which JNK1 affects TGF-β1 signaling could
be manyfold, based upon the complexities of the TGF-β and JNK
signaling cascades. This interaction may include direct
Fig. 5. Wild-type and JNK1–/– MTEC display similar growth, morphology and
production of mucin in culture. (A) Growth curves of MTEC derived from
wild type and JNK1–/– were conducted for the indicated times, and cell
numbers were assessed by evaluation of total DNA content. (B) Wild-type and
JNK1–/– cells established tight junctions, as shown by scanning electron
microscopy. (C) Wild-type and JNK1–/– MTEC maintained in ALI for 10 days
in the presence of 30 nM retinoic acid produced mucin. Media from two
independent cultures from each condition were analyzed by slot blot analysis,
using an anti-mucin antibody. Different dots shown represent results from
independent samples.
Fig. 6. TGF-β1 induces EMT transcriptional responses in MTEC in a JNK1-
dependent manner. (A) TGF-β1-induced gene expression changes obtained via
microarray analysis are blunted in JNK1 MTEC compared with wild-type
cells. Data plot shows the fold change (2n) in gene expression induced by
TGF-β1 compared to sham controls (TGF-β1-treated, sham controls) for wild-
type MTEC (x-axis) and JNK1–/– MTEC (y-axis). The dashed line depicts the
normal distribution expected if the gene expression changes were similar in
wild-type and JNK1–/– MTEC. The solid line depicts the mean gene
expression changes observed, and indicate a blunted response to TGF-β1 in
JNK1–/– MTEC. Horizontal and vertical gray dotted lines represent the twofold
change cutoffs. (B) TGF-β1-dependent modulation of mesenchymal and
epithelial gene expression in MTEC depends on JNK-1. MTEC were treated
with 5 ng/ml TGF-β1 for the indicated times and RNA evaluated by Taqman
analysis. Data are represented as fold change in expression compared to sham
controls (n=2, representative of five independent experiments). (C) TGF-β1
enhanced expression of known EMT regulatory transcription factors in a
JNK1-dependent manner as assessed by Taqman analysis. * P<0.05, ANOVA
versus wild-type MTEC. CCSP, clara cell secretory protein; Col1a1, collagen
type 1a1; Fn1, fibronectin 1; HMGA 2, high mobility group AT-hook 2; Jag-1,
jagged-1; PAI-1, plasminogen activator inhibitor 1.
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phosphorylation of Smads, in addition to phosphorylation of Jun,
a crucial component of the activator protein 1 (AP-1) transcription
factor that can in some cases cooperate with Smads to drive TGF-
β1-dependent transcription (Derynck and Zhang, 2003; Hocevar et
al., 1999; Javelaud and Mauviel, 2005; Zhang et al., 1998). TGF-
β1-induced phosphorylation of Smad2 and Smad3 has been shown
to be JNK-dependent, and to mediate the transcriptional
upregulation of connective tissue growth factor (CTGF),
plasminogen activator inhibitor (PAI-1) and matrix
metalloproteinase 2 (Kasai et al., 2005; Mori et al., 2004; Wang et
al., 2006; Xie et al., 2005). An elegant study recently demonstrated
that active JNK is directly capable of phosphorylating Smad2 and
Smad3 in the linker regions at consensus MAPK phosphorylation
sites. Smad2/3 linker phosphorylation by JNK was shown to
promote their association with Smad4, and was crucial in the
augmentation of PAI-1 gene expression (Mori et al., 2004). In direct
contrast to our present observations, and the studies cited above,
JNK has also been shown to abrogate the effects of TGF-β (Dennler
et al., 2000; Verrecchia et al., 2001). JNK-dependent
phosphorylation of Jun has been shown to inhibit Smad3-dependent
transcription (Dennler et al., 2000), and to mediate the antagonistic
effects of inflammatory cytokines on TGF-β signaling (Verrecchia
et al., 2003). Mouse embryonic fibroblasts from JNK1 and JNK2
double null mice produced elevated levels of TGF-β in vitro, and
displayed markedly altered expression patterns of many genes
crucial to TGF-β signaling, demonstrating a role for JNK as a
repressor of TGF-β1 transcription (Ventura et al., 2004). These
disparate effects of JNK1 probably reflect the cell- and stimulus-
specific context of JNK and TGF-β1 signaling outcomes, and the
integration with additional signals.
The possibility exists that JNK1–/–-deficient airway epithelial cells
are resistant to TGF-β1 signals due to intrinsic differences in
expression of TGF-β pathway components. However, evaluation
of Smad2/3 expression levels and TGF-β1-induced Smad2/3
carboxyterminal phosphorylation revealed virtually identical
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responses to TGF-β1 in wild-type and JNK1–/– cells, demonstrating
that the proximal TGF-β1 pathway is intact in JNK1–/– airway
epithelial cells. Thus, the attenuation of EMT in JNK1–/– epithelial
cells is probably due to dampening of downstream TGF-β1-induced
transcriptional activation, results supported by gene expression
profiling (Fig. 5). Our findings are in contrast with a recent
observation in which JNK1–/– lung fibroblasts demonstrated
attenuation of Smad2 phosphorylation, and nuclear accumulation
of Smad2 and Smad3 in response to administration of TGF-β1, in
comparison to wild-type cells (Wang et al., 2006). Furthermore, in
that study, TGF-β1-induced expression of collagen 1 and fibronectin
was not attenuated in JNK1–/– cells, compared to fibroblasts isolated
from wild-type mice. Instead, the authors revealed that JNK1
appeared to play a crucial role in the caveolin-1-mediated
suppression of TGF-β1-induced production of extracellular matrix.
These disparate results are intriguing, and again suggest that the
molecular action of JNK1 in interpreting and relaying TGF-β1-
induced signals may be highly cell-type- and context-dependent.
The molecular actions of JNK1 in the causation of apoptosis are
well known and have been extensively described (Davis, 2000). As
TGF-β1 has been shown to cause apoptosis in epithelial cells, and
apoptosis is required for pulmonary collagen deposition (Lee et al.,
2004), it can be extrapolated that JNK1 could play a role in EMT
as a consequence of apoptosis. However, a number of observations
do not support this hypothesis. First, experiments that used the
generic caspase inhibitor zVAD (10 μM) revealed that TGF-β1-
induced loss of TER (supplementary material Fig. S3) or increases
in mesenchymal gene expression (supplementary material Fig. S4)
were not affected by the caspase inhibitor, whereas, as expected,
zVAD blocked FasL-induced caspase 3 cleavage (supplementary
material Fig. S5). Second, a recent study that dissected the molecular
actions of TGF-β1 in cells in different stages of the cell cycle
demonstrated that TGF-β1-induced EMT was prominent in cells in
G1/S phases of the cell cycle, when caspase activity was low,
whereas in cells in G2/M phase EMT was low, with caspase activity
being high, suggesting a disparity between caspase activation and
EMT (Yang et al., 2006). Third, TGF-β1-induced cell cycle arrest
in epithelial cells, which precedes apoptosis, was also demonstrated
to be uncoupled from induction of mesenchymal gene expression
(Laiho et al., 1991). Collectively, these observations suggest that
the molecular action of JNK1 in the induction of EMT in airways
appears to be uncoupled from its well-known role in apoptosis.
A variety of potential mechanisms exist by which JNK1 might
regulate EMT. The data presented herein suggest that JNK1 acts
as a regulator of TGF-β1-induced transcriptional regulation. Smad
DNA-binding and the mRNA levels of known EMT regulators
Jagged 1, HMGA 2, Ets-1 and Wnt5a (Table 1, Fig. 6C) were all
decreased in JNK1–/– MTEC versus wild-type controls. Recently
in a kidney epithelial cell line, a novel transcriptional complex was
described at the fibroblast transcription site FTS-1, which contained
CArG box-binding factor-A (CBF-A) and KRAB-associated protein
1 (KAP-1). The authors furthermore demonstrated that CBF-A was
a proximal activator of transcription in EMT, and that FTS-1
promoter regions were found in many genes functionally linked to
EMT, including α-SMA, collagen type 1a1 and HMGA 2 (Venkov
et al., 2007), which we demonstrated here to be modulated by TGF-
β1 in a JNK1-dependent manner. It is therefore intriguing to
speculate that JNK1 may be required for CBF-A induction by TGF-
β1, which then controls subsequent activation of EMT-related genes.
Another possible mechanism by which JNK1 could promote EMT
might involve the regulation of Wnt5a production, as suggested by
Fig. 7. Evaluation of TGF-β1 pathway activation in wild-type and JNK1–/–-
deficient MTEC. (A) Assessment of nuclear accumulation of phospho-Smad2
(P-Smad2), Smad2, P-Smad3, Smad3, Smad4 and P-Jun in wild-type or
JNK1–/– MTEC after exposure to 5 ng/ml TGF-β1 for 120 or 240 minutes.
(B) Assessment of binding of nuclear proteins to the consensus SBE via
electrophoretic mobility shift analysis in wild-type or JNK1–/– MTEC after
exposure to 5 ng/ml TGF-β1 for 120 or 240 minutes. Different lanes shown
represent results from independent samples.
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our gene expression analysis. Wnt5a has been shown to induce snail
and vimentin, and to decrease E-cadherin levels consistent with
EMT (Dissanayake et al., 2007). Lastly, JNK1 might be crucial to
EMT via its role in regulating RhoA signaling via activation of JNK
by ROCK and subsequent Jun phosphorylation (Marinissen et al.,
2004). RhoA has been linked to loss of tight junctions and changes
in cell structure and motility associated with EMT (Fan et al., 2007;
Martin-Villar et al., 2006; Ozdamar et al., 2005). In addition, the
RhoA-ROCK-JNK pathway has been linked to myofibroblast
differentiation and increases of α-SMA expression (Smith et al.,
2006). Based upon these reports, the molecular pathways by which
JNK1 facilitates the process of EMT induced by TGF-β1 are likely
to be complex and diverse.
The extent of fibrosis has been directly linked with poor prognosis
in various human diseases (Elias et al., 1999), and the functional
importance of TGF-β1 herein has been highlighted (Leask and
Abraham, 2004). The present work identifies JNK1 as a crucial
amplifier of TGF-β1 signaling in promoting EMT. Strategies to
specifically attenuate the molecular actions of JNK1 in the TGF-
β1 signaling module could have therapeutic value towards the
attenuation of tissue fibrosis for which present therapeutic modalities
have been proven to be ineffective. Findings from our study also
suggest a functional significance of epithelial plasticity in
fibrogenesis in the lung.
Materials and Methods
Animals and reagents
C57BL/6 mice, 2-4 months old, were originally purchased from Charles River
Laboratories (Ste. Constant, QE, Canada) and were maintained within the colony as
control animals. JNK1–/– and JNK2–/– mice were backcrossed more than ten
generations into the C57Bl/6 background and have been previously described (Dong
et al., 1998; Yang et al., 1998). Animal studies were approved by the Institutional
Animal Care and Use Committee at the University of Vermont. All chemicals utilized
were purchased from Sigma-Aldrich (St Louis, MO) unless otherwise noted. Smad2,
Smad3 and phospho-JNK antibodies were obtained from Cell Signaling Technology
(Danvers, MA); antibodies to JNK1, PAI-1 and ZO-1 were from Santa Cruz
Biotechnology (Santa Cruz, CA). Pan-cytokeratin and E-cadherin antibodies were
purchased from Zymed (San Francisco, CA), Fibronectin-1 antibody was from
Chemicon (Temecula, CA), and Collagen type 1a1 antibody was purchased from
Fitzgerald Industries International (Concord, MA). The mucin antibody utilized was
a gift from Samuel B. Ho (University of Minnesota).
Primary MTEC and fibroblast culture
MTEC cultures were isolated according to previously published methods (Wu and
Smith, 1982). Briefly, tracheas were isolated, filled with 0.1% protease Type 14 in
minimum essential media and incubated overnight at 37°C. The following day,
tracheas were flushed, and MTEC were propagated on rat tail collagen I gel (BD
Biosciences, San Jose, CA) coated tissue culture flasks in DMEM/F12 media
containing 20 ng/ml cholera toxin (List Biologicals Laboratories, Campbell, CA), 4
μg/ml insulin, 5 μg/ml transferrin, 5 μg/ml bovine pituitary extract (Invitrogen,
Carlsbad, CA), 10 ng/ml epidermal growth factor (EMD Biosciences, San Diego,
CA), 100 nM dexamethasone, 2 mM L-glutamine and 50 U/50 μg/ml of Pen/Strep
(Invitrogen). For experiments, MTEC were plated on collagen-I-coated culture dishes
(BD Biosciences) or Transwell plates (12 mm well diameter, 0.4 μm pore size)
(Corning Inc., Corning, NY) that were coated with rat tail collagen (50 μg/ml) and
grown to confluence or 1000Ωcm2 TER before initiation of experiments. Lung
fibroblast cultures were prepared by digestion of lung pieces using 0.2% trypsin
(Invitrogen, Carlsbad, CA), 0.1% collagenase type IV (Invitrogen) and 400 μg/ml
DNAse (Worthington) for 30 minutes. The digest was then filtered with a 70 μm
filter and released cells were cultured in DMEM with 10% fetal bovine serum
(Invitrogen).
ALI culture
After growing cells to 1000Ωcm2 on transwells, the media in the upper chamber
was removed. Cells were then fed every other day in the lower chamber and TER
was measured by washing the upper chamber with media then removing it. Trans-
retinoic acid (30 nM; Sigma-Aldrich) was added to the lower chamber as indicated.
MTEC growth curve
Cells were plated and grown as above until the indicated days of harvest. To measure
the total DNA, cells were washed twice with HBSS and then fixed for 10 minutes
with ice-cold 70% ethanol plus 500 μl 5 M sodium hydroxide. Samples were then
read at 260 nm.
Immunocytochemistry
At the indicated times for staining, cells were washed twice with PBS then fixed for
20 minutes with 4% paraformaldehyde in PBS. Following fixation, cells were
permeablized for 10 minutes with 100% methanol, washed twice with PBS, and then
blocked with PBS plus 1% BSA. Primary antibodies were then incubated as indicated
by the manufacturer, and AlexaFluor (Molecular Probes, Eugene, OR) secondary
antibodies were used for imaging. Images were collected by fluorescence microscopy.
Measurement of gene expression
Total RNA was isolated from MTEC using the RNeasy Mini Kit (Qiagen, Valencia,
CA), subjected to reverse transcription and DNase treatment to produce cDNA for
Taqman gene analysis using Assays on Demand for the individual target genes
(Applied Biosystems, Foster City, CA).
Microarray analysis of gene expression
cDNA from primary MTEC isolated as outlined above was subjected to gene array
analysis using a two-factor Affymetrix GeneChip experiment, using 430A 2.0 Array
chips. GCOS (Affymetrix, Santa Clara, CA) was used to calculate the signal intensity
for each probe and sample. Bioconductor software was used to calculate the RNA
summary expression statistic for each probe set and sample (Bolstad et al., 2003;
Irizarry et al., 2003). R was used to implement linear models that support estimation
of expression statistics for each probe set and treatment group and to test hypotheses
expressed as linear combination of the resulting values. Biological processes, cellular
components and molecular functions associated with sets of differentially regulated
probe sets were identified based on Gene Ontology (GO) annotation (Camon et al.,
2003).
Evaluation and manipulation of JNK
MTEC cells were treated with TGF-β1 (5 ng/ml) for 1, 2 or 4 hours. Lysates were
prepared for evaluation of phosphorylation of JNK1 and 2 by western blotting. Blots
were evaluated by densitometry and fold changes in JNK1 or JNK2 phosphorylation
were compared to control samples calculated after normalization to total JNK1 and
2 expression levels. JNK was inhibited pharmacologically using SP600125
(Calbiochem; La Jolla CA). MTEC were incubated with 10 μM SP600125 for 30
minutes before exposure to TGF-β1. A line of mouse alveolar type II epithelial cells
(C10) (Malkinson et al., 1997) were incubated with Dharmacon SMARTpool control
non-targeting siRNA (100 nM) or Dharmacon SMARTpool siRNA specific against
JNK1 (100 nM) (Lafayette; CO) and subsequently exposed to TGF-β1 for 2 days
for evaluation of mRNA expression using Taqman analysis.
Determination of TER
MTEC were grown on transwell culture plates (BD Biosciences, Bedford, MA). After
culture to confluence, TER was measured in the media using an EVOM Epithelial
Voltohmeter following the manufacturer’s instructions (World Precision Instruments,
Sarasota, FL).
Protein nuclear extraction and EMSA
Nuclear extracts from MTEC were prepared after lysing cells in hypotonic buffer,
followed by incubation with 10% NP-40. Nuclei were pelleted, and suspended in
hypertonic buffer to extract nuclear proteins (Janssen et al., 1997). EMSA was then
performed with oligonucleotides containing SBE DNA-binding motifs (Promega,
Madison, WI).
Scanning electron microscopy analyses
Cells were grown on transwell dishes as described above. Cells were fixed in 2%
glutaraldehyde in PBS at 4°C for 1 hour and were post-fixed in 1% osmium tetroxide
in 0.05 M cacodylate buffer, pH 7.2 for 1 hour at room temperature. Next cells were
immersed in 1% tannic acid in cacodylate buffer for 1 hour at room temperature and
then immersed in 0.5% uranyl acetate in dH2O for 1 hour at room temperature.
Following fixation, cells were dehydrated in ethanol series using 10 minutes each in
25, 50, 75 and 85% ethanol. Then two times 10 minutes in 95%, and three times 15
minutes in anhydrous 100% ethanol. Then, 100-150 ml of hexamethyldisilazine
(Sigma-Aldrich) was added into each insert and allowed to evaporate overnight in a
fume hood. The Transwell membranes were removed using a scalpel, attached to 12
mm diameter aluminum specimen holders using colloidal graphite (Ladd Research
Industries, Inc) and allowed to dry overnight. The next day, specimens were sputter
coated with gold/palladium in Polaron sputter coater (Model 5100). Specimens were
imaged on a JSM-6060 scanning electron microscope from JEOL USA, Inc.
(Peabody, MA).
Transmission electron microscopy analyses
Cells were washed with 0.1 M Millonig’s phosphate buffer (pH 7.2), then fixed in
1:1 H2O dilution of Karnovsky’s fixative (2.5% glutaraldehyde, 1% paraformaldehyde)
at 4°C for 45 minutes. Samples were then washed with Millonig’s phosphate buffer
(pH 7.2), and post-fixed in 1% osmium tetroxide (OsO4) at 4°C for 30-45 minutes.
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Samples were then dehydrated in graded ethanols, from 35% to 100%. Cells were
then infiltrated with Spurr’s resin according to the following schedule: (100%
ethanol:Spurr’s resin) 3:1 for 30 minutes; 1:1 for 30 minutes; 1:3 for 30 minutes;
and 100% Spurr’s resin for 30 minutes. Flat embedding molds were filled with Spurr’s
resin, and cells were placed onto the surface of the resin, cell side down. Resin was
then polymerized overnight at 70°C. Semi-thin sections (1 μm) were cut using glass
knives on a Reichert Ultracut microtome, stained with Methylene Blue-Azure II and
evaluated for areas of cells. Ultra-thin sections (60-80 nm) were cut with a diamond
knife, retrieved onto 150 mesh copper grids, contrasted with uranyl acetate (2% in
50% ethanol) and lead citrate, and examined with a JEM 1210 transmission electron
microscope (JEOL USA, Inc.) operating at 60 kV.
Statistical analyses
Data were analyzed by one-way ANOVA, using the Fisher’s least significant
difference test to adjust for multiple comparisons. Where appropriate, data were
analyzed by unpaired two-tailed t-tests. Analyses with resultant P<0.05 were accepted
as statistically significant. All statistics were performed using the Microsoft Excel
software package (Redmond, WA). Data from individual experiments are presented
as mean value ± standard error of the mean, and all experiments, with the exception
of microarray analysis, were repeated at least three times.
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